NLS Pharmaceutics Ltd. (NASDAQ:NLSP – Get Free Report) saw a significant decline in short interest in the month of February. As of February 28th, there was short interest totalling 58,200 shares, a decline of 65.7% from the February 13th total of 169,500 shares. Approximately 3.7% of the shares of the company are short sold. Based on an average trading volume of 2,650,000 shares, the short-interest ratio is presently 0.0 days.
NLS Pharmaceutics Stock Performance
Shares of NASDAQ NLSP traded up $0.05 during midday trading on Friday, hitting $1.58. 15,211 shares of the company’s stock were exchanged, compared to its average volume of 2,928,176. The stock’s 50 day moving average price is $1.98 and its 200-day moving average price is $2.42. NLS Pharmaceutics has a twelve month low of $1.47 and a twelve month high of $18.39.
NLS Pharmaceutics Company Profile
Featured Stories
- Five stocks we like better than NLS Pharmaceutics
- Best Aerospace Stocks Investing
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- How to Find Undervalued Stocks
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Dividend Payout Ratio Calculator
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for NLS Pharmaceutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NLS Pharmaceutics and related companies with MarketBeat.com's FREE daily email newsletter.